Module 7: Special Populations
Lipid management considerations for special populations including women, older adults, and ethnic groups.
Special Population Guidance
Select a population for guideline-specific statin and lipid management recommendations
Chronic Kidney Disease Assessment
Enter Estimated GFR to see stage-specific guidance
Statin Guidance
Class I / Level C-EOFollow standard statin recommendations. Chronic kidney disease is a recognized risk-enhancing factor.
Recommendation
Chronic kidney disease stage 1-2 (estimated GFR ≥60): Manage lipids per standard primary or secondary prevention pathways. Chronic kidney disease at this stage is a risk-enhancing factor that favors statin initiation. No chronic kidney disease-specific recommendation exists for stages 1-2.
Source: Clinical practice — no CKD-specific recommendation for stages 1-2; manage per standard pathways
Understanding the Evidence Rating
Drug Interactions & Contraindications
Drug Interactions
Avoid simvastatin >20 mg with cyclosporine
Preferred statins in chronic kidney disease: atorvastatin, rosuvastatin, pitavastatin (renal-safe profiles)
Clinical Pearls
- Chronic Kidney Disease is a recognized risk-enhancing factor at any stage.
- Statins do not adversely affect kidney function and may slow Chronic Kidney Disease progression.
- PCSK9 Monoclonal Antibodies have not been studied in those with GFR <20 mL/min/1.73 m²; use with caution at very low Estimated GFR.
- Rosuvastatin should be capped at 10 mg for Estimated GFR <30.
- Chronic Kidney Disease + atherosclerotic cardiovascular disease: high-intensity statin, target LDL Cholesterol <55 mg/dL, Non-HDL Cholesterol <85 mg/dL (Rec 2, Class I, Level B-R).
IMPORTANT: This software is clinical decision support (CDS) intended for use by licensed healthcare professionals under Section 520(o)(1)(E) of the Federal Food, Drug, and Cosmetic Act. It is not intended as a medical device. All recommendations are derived from the 2026 ACC/AHA Guideline on the Management of Dyslipidemia and must be independently verified by the treating clinician before any clinical action. AI-generated content (including extracted data and clinical notes) is produced by large language models and may contain errors, omissions, or hallucinations — clinician review is mandatory. Patient data entered into the calculator is processed entirely in the browser; AI features process data server-side under a signed HIPAA Business Associate Agreement with no data retention. AI-HEART Lab, its affiliates, and contributors assume no liability for clinical decisions made using this tool. By using this tool, you acknowledge these limitations and accept full responsibility for clinical decisions.